Correspondence 0001213900-23-022446 from Jin Medical International Ltd. (ZJYL)
Jin Medical International Ltd.
Date: March 23, 2023 · CIK: 0001837821 · Accession: 0001213900-23-022446
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-259767
Letter
VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Washington, D.C. 20549 Re: JIN MEDICAL INTERNATIONAL LTD. Registration Statement on Form F-1, as amended File No. 333-259767
Dear Ms. Park:
In accordance with Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, JIN MEDICAL INTERNATIONAL LTD. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 pm, Eastern Time, on March 27, 2023, or as soon thereafter as practicable.
Very truly yours,
JIN MEDICAL INTERNATIONAL LTD.
Show Raw Text
CORRESP
1
filename1.htm
JIN MEDICAL INTERNATIONAL LTD.
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People’s Republic of China
VIA EDGAR
March 23, 2023
Ms. Jane Park
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F. Street, N.E.
Washington, D.C. 20549
Re:
JIN MEDICAL INTERNATIONAL LTD.
Registration Statement on Form F-1, as amended
File No. 333-259767
Dear Ms. Park:
In accordance with Rule 461
of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended,
JIN MEDICAL INTERNATIONAL LTD. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it
will become effective at 5:00 pm, Eastern Time, on March 27, 2023, or as soon thereafter as practicable.
Very truly yours,
JIN MEDICAL INTERNATIONAL LTD.
By:
/s/ Erqi Wang
Name:
Erqi Wang
Title:
Chief Executive Officer and Chairman of the Board of Directors
cc. Ying Li, Esq., Hunter Taubman Fischer &
Li LLC